Background: The role of calcium hydroxylapatite injection pharyngoplasty after failed sphincter pharyngoplasty surgery has not previously been described. We report our technique of injecting calcium hydroxylapatite into the pharyngoplasty site to add bulk to specific areas of the velopharyngeal port. Methods: A retrospective review of children undergoing calcium hydroxylapatite injection pharyngoplasty for persistent velopharyngeal insufficiency after sphincter pharyngoplasty was performed. Our surgical technique is described. Outcome measures included postoperative perceptual assessment of resonance, improvement in phoneme-specific nasometry scores, and rate of revision surgery. Results: Fourteen patients were included in the study. Improvement in hypernasality on perceptual assessment was noted in the majority of children (85.7%). The rate of achievement of normal resonance on perceptual analysis was 35.7%. A significant decrease in nasometry scores was noted for the following phonemes: /pa/, /sa/, /sha/, and /pi/. There were no intraoperative complications or immediate postoperative complications associated with calcium hydroxylapatite injection. Conclusions: Our early experience suggests that calcium hydroxylapatite injection after failed sphincter pharyngoplasty is a safe, minimally invasive technique with favorable short-term results.

1.
O'Connell BP, Dobbie AM, Oyer SL, et al: The impact of adenoid size on rate of revision sphincter pharyngoplasty. Laryngoscope 2014;124:2170-2175.
2.
Losken A, Williams JK, Burstein FD, et al: An outcome evaluation of sphincter pharyngoplasty for the management of velopharyngeal insufficiency. Plast Reconstr Surg 2003;112:1755-1761.
3.
Sadick NS, Katz BE, Roy D: A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face. Dermatol Surg 2007;33:S122-S126.
4.
Brigger MT, Ashland JE, Hartnick CJ: Injection pharyngoplasty with calcium hydroxylapatite for velopharyngeal insufficiency: patient selection and technique. Arch Otolaryngol Head Neck Surg 2010;136:666-670.
5.
Ettinger RE, Oppenheimer AJ, Lau D, et al: Obstructive sleep apnea after dynamic sphincter pharyngoplasty. J Craniofac Surg 2012;23:1974-1976.
6.
Bass LS, Smith S, Busso M, et al: Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results. Aesthet Surg J 2010;30:235-238.
7.
Carruthers A, Libeskind M, Caruthers J, et al: Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV-associated facial lipoatrophy and correction of nasolabial folds. Dermatol Surg 2008;24:S78-S84.
8.
Berline AL, Hussain M, Goldberg DJ: Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunochemical analysis. Dermatol Surg 2008;34:S64-S67.
9.
Coleman KM, Voigts R, DeVore DP, et al: Neocollagenesis after injection of calcium hydroxylapatite composition in a canine model. Dermatol Surg 2008;34:S53-S55.
10.
Bishop A, Hong P, Bezuhly M: Autologous fat grafting for the treatment of velopharyngeal insufficiency: state of the art. J Plast Reconstr Aesthet Surg 2014;67:1-8.
11.
Piotet E, Beguin C, Broome M, et al: Rhinopharyngeal autologous fat injection for treatment of velopharyngeal insufficiency in patients with cleft palate. Eur Arch Otorhinolaryngol 2015;272:1277-1285.
12.
Lau D, Oppenheimer AJ, Buchman SR, et al: Posterior pharyngeal fat grafting for velopharyngeal insufficiency. J Craniofac Surg 2012;23:1974-1976.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.